Novartis dealt another Galvus setback
November 07 2007
Newly discovered liver safety problems with high doses of Novartis' diabetes treatment Galvus are expected to delay the European launch ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.